Wed, Nov 26, 2014, 9:55 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Omeros Corporation (OMER) Message Board

  • alias_known alias_known Apr 6, 2010 6:34 PM Flag

    IPO Over-Allotment

    Deutsche Bank exercised the over-allotment option for Anthera IPO. Why didn't Deutsche Bank do the same thing as the lead underwriter for the Omeros IPO?

    Anthera Pharmaceuticals Announces Closing of Underwriters' Exercise of Over-Allotment Option in Connection With Its Initial Public Offering

    HAYWARD, Calif., April 6 /PRNewswire-FirstCall/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, today announced the closing of the underwriters' exercise of their over-allotment option to purchase an additional 604,492 shares of Anthera's common stock. The sole book-running manager of the offering is Deutsche Bank Securities Inc. Piper Jaffray & Co. is a co-lead manager of the offering and Cowen and Company, LLC and Merriman Curhan Ford & Co. are co-managers of the offering.

22.41+0.58(+2.66%)Nov 26 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.